B-Lite™ – The new implants to revolutionise Breast Augmentation
At last week’s ESPRAS’ meeting I was able to introduce this amazing technology and the trials so far.
Breast augmentation currently ranks as the most popular plastic surgery procedure in the states, and always comes in the top five procedures worldwide. Since the 1980’s, when the most popular size was 250cc, we have seen a steady increase in size preferential – in the 2000’s it rose to 350cc and larger.
As a result of this, there are a number of problems that can occur:
- Breast tissue atrophy
- Skin atrophy and Stretch marks
- Accelerated Ptosis (Sagging)
- Nipple and areolar complex displacement
- Inframammary fold breakdown
- Deformity of the breast
- Traction rippling
- Prominence of implants through breast tissue
- Back, shoulder and neck pain
The force exerted on breast tissue is in direct proportion to implant weight – the heavier the implant, the stronger gravity pulls resulting in compromised tissue elasticity. In addition, physical activity creates significant movement in breasts and movement amplitude is in direct proportion to weight although breast volume has no effect on amplitude.
So with these facts in mind, evolution is on the horizon in the form of the new B-Lite Implant! It is filled with a microsphere enhanced silicone gel, with a shell that is of standard industry silicone, and this gel allows for a weight reduction of 30%. In pre-clinical mechanical, chemical and biological tests, the results demonstrated that all tests were passed successfully and that there was in fact superior product safety over standard implants.
For the patient, there are a number of advantages to the B-Lite™ implants:
- All the materials used in B-Lite are well known and biocompatible
- There is no change in the surgical procedure
- Patented microsphere-gel adhesion (no separation in case of implant rupture)
- Reduced gel bleed over the life of the implant
- Significantly less silicone gel in implant
In initial surgical testing in December 2013 with 50 subjects, there was a very high surgeon satisfaction in all 50 cases and 94% patients were satisfied with the procedure. It can therefore be concluded that the new Light Weight Breast Implant has proven Pre-clinical safety, early clinical safety and efficacy and may be a solution to limiting the soft tissue effects of breast implants.